280 related articles for article (PubMed ID: 15571264)
21. Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype.
Arenas M; Duley JA; Ansari A; Shobowale-Bakre EA; Fairbanks L; Soon SY; Sanderson J; Marinaki AM
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1403-5. PubMed ID: 15571267
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
23. Genomic structure and multiple single-nucleotide polymorphisms (SNPs) of the thiopurine S-methyltransferase (TPMT) gene.
Seki T; Tanaka T; Nakamura Y
J Hum Genet; 2000; 45(5):299-302. PubMed ID: 11043513
[TBL] [Abstract][Full Text] [Related]
24. Application of SNaPshot for analysis of thiopurine methyltransferase gene polymorphism.
Kapoor G; Maitra A; ; Brahmachari V
Indian J Med Res; 2009 May; 129(5):500-5. PubMed ID: 19675376
[TBL] [Abstract][Full Text] [Related]
25. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.
Brouwer C; De Abreu RA; Keizer-Garritsen JJ; Lambooy LH; Ament K; ter Riet PG; van Wering ER; Trijbels FJ; Veerman AJ; Hoogerbrugge PM; Bökkerink JP
Eur J Cancer; 2005 Mar; 41(4):613-23. PubMed ID: 15737567
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.
McLeod HL; Krynetski EY; Relling MV; Evans WE
Leukemia; 2000 Apr; 14(4):567-72. PubMed ID: 10764140
[TBL] [Abstract][Full Text] [Related]
27. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.
Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene.
Appell ML; Wennerstrand P; Peterson C; Hertervig E; Mårtensson LG
Pharmacogenet Genomics; 2010 Nov; 20(11):700-7. PubMed ID: 20881512
[TBL] [Abstract][Full Text] [Related]
29. Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
Schmiegelow K; Forestier E; Kristinsson J; Söderhäll S; Vettenranta K; Weinshilboum R; Wesenberg F;
Leukemia; 2009 Mar; 23(3):557-64. PubMed ID: 18987654
[TBL] [Abstract][Full Text] [Related]
30. Screening of thiopurine S-methyltransferase mutations by horizontal conformation-sensitive gel electrophoresis.
Alves S; Prata MJ; Ferreira F; Amorim A
Hum Mutat; 2000; 15(3):246-53. PubMed ID: 10679940
[TBL] [Abstract][Full Text] [Related]
31. Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.
Lennard L; Cartwright CS; Wade R; Vora A
Br J Haematol; 2015 Apr; 169(2):228-40. PubMed ID: 25441457
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics.
Hartford C; Vasquez E; Schwab M; Edick MJ; Rehg JE; Grosveld G; Pui CH; Evans WE; Relling MV
Cancer Res; 2007 May; 67(10):4965-72. PubMed ID: 17510427
[TBL] [Abstract][Full Text] [Related]
33. Development of a rapid clinical TPMT genotyping assay.
Burchard PR; Abou Tayoun AN; Lefferts JA; Lewis LD; Tsongalis GJ; Cervinski MA
Clin Biochem; 2014 Oct; 47(15):126-9. PubMed ID: 25093923
[TBL] [Abstract][Full Text] [Related]
34. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M
JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872
[TBL] [Abstract][Full Text] [Related]
35. Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia.
Yang JJ; Bhojwani D
Methods Mol Biol; 2013; 999():273-84. PubMed ID: 23666706
[TBL] [Abstract][Full Text] [Related]
36. Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies.
Franca R; Braidotti S; Stocco G; Decorti G
Expert Opin Drug Metab Toxicol; 2021 Oct; 17(10):1187-1198. PubMed ID: 34452592
[TBL] [Abstract][Full Text] [Related]
37. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.
Pettersson B; Almer S; Albertioni F; Söderhäll S; Peterson C
Ther Drug Monit; 2002 Jun; 24(3):351-8. PubMed ID: 12021625
[TBL] [Abstract][Full Text] [Related]
38. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
Gardiner SJ; Gearry RB; Begg EJ; Zhang M; Barclay ML
Clin Gastroenterol Hepatol; 2008 Jun; 6(6):654-60; quiz 604. PubMed ID: 18467186
[TBL] [Abstract][Full Text] [Related]
39. The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation.
Fabre MA; Jones DC; Bunce M; Morris PJ; Friend PJ; Welsh KI; Marshall SE
Transpl Int; 2004 Oct; 17(9):531-9. PubMed ID: 15349717
[TBL] [Abstract][Full Text] [Related]
40. The thiopurines: an update.
Coulthard S; Hogarth L
Invest New Drugs; 2005 Dec; 23(6):523-32. PubMed ID: 16267626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
